Sr. Director, Biostatistics
External
Atavistik-bio · Cambridge, MAPrepare for this interview
EliteAI-generated questions, company research, and talking points tailored to this role
Requirements
- PhD in statistics strongly preferred; Candidates with MS in statistics, biostatistics or mathematics and a depth of relevant experience in drug development statistical research will be considered
- A minimum of 8 years' experience in progressive and relevant clinical trial experience
- Experience leading teams and working in a matrix organization
- Experience with blinded study designs and analyzing and interpreting patient reported outcome (PRO) data sets strongly preferred
- Ability to communicate and work directly with non-statisticians imparting and delivering complex statistical information to scientific development partners and researchers
- Excellent communication with an ability to present to a variety of stakeholders and tailor message accordingly
- Experience managing CROs and other data vendors
- Strong leader with a growth mindset, willing to learn from others, and dedicated to promoting a collaborative work culture
- Ability to keep pace in a fast-moving organization and navigate ambiguity
- Advanced knowledge of statistical methods in clinical study designs (adaptive, Bayesian), statistical analysis methods including Bayesian method, missing data imputation, multiplicity adjustment
- Knowledge and proficiency in SAS or R and other industry computational tools
- Knowledge of CDISC standard including SDTM, ADaM
- Knowledge of ICH guidelines, FDA / EMA / other regulatory authority guidance
- Experience in planning, running and documenting simulations, including clinical trial simulations
- Experience working on site and with remote teams
Benefits
Additional Information
Company Summary: Atavistik Bio is a privately-held clinical stage biotechnology company accelerating the discovery and development of transformative precision allosteric therapeutics to address serious unmet patient needs. Our proprietary AMPS™ platform allows us to rapidly unlock functional cryptic pockets across a broad range of target classes to accelerate the development of groundbreaking medicines. We have rapidly established an emerging pipeline of allosteric therapeutics with the potential to achieve superior efficacy and tolerability profiles by leveraging the power of allostery. Atavistik Bio is led by an experienced team of drug hunters with a proven track record of developing marketed small molecule therapies and supported by top-tier investors, including The Column Group, Nextech Invest, Lux Capital, Regeneron Ventures, and RA Capital Management.
Your Match
How well this role fits your profile.
Company Intel
What employees say
Worked at atavistik-bio? Share your experience